Intravenous iron therapy ameliorates iron parameters in patients with heart failure who present iron deficiency: serum ferritin <100 mg/L or 100–299 mg/L when transferrin saturation <20%, with or without cardiorenal syndrome or renal disease. Here, TF is linked to Iron deficiency anemia.